Cellebrite DI Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep '24 Sep 30, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Revenue	385.17	325.11	270.65	246.25	194.91	171.85
Revenue Growth (YoY)	25.82%	20.12%	9.91%	26.34%	13.42%	-
Cost of Revenue	59.89	53.23	50.75	42.56	37.88	35.82
Gross Profit	325.28	271.88	219.91	203.69	157.03	136.03
Selling, General & Admin	174.54	154.26	138.24	124.33	91.59	90.98
Research & Development	94.57	84.39	80.62	65.54	54.38	46.57
Operating Expenses	269.1	238.64	218.86	189.87	145.97	137.55
Operating Income	56.18	33.24	1.04	13.82	11.07	-1.52
Interest & Investment Income	8.89	8.89	1.6	0.85	2.71	3.48
Currency Exchange Gain (Loss)	0.21	0.21	0.85	-0.19	-0.45	-0.19
Other Non Operating Income (Expenses)	-117.89	-117.89	117.27	67.83	-0.09	-0.35
EBT Excluding Unusual Items	-308.23	-75.56	120.76	82.31	13.25	1.42
Merger & Restructuring Charges	-	-	-	-	-1.85	-
Pretax Income	-308.23	-75.56	120.76	82.31	11.4	1.42
Income Tax Expense	8.7	5.54	-0.05	10.91	5.62	3.29
Net Income	-316.92	-81.1	120.81	71.4	5.78	-1.88
Preferred Dividends & Other Adjustments	-	-	4.69	0.96	15.13	8.16
Net Income to Common	-316.92	-81.1	116.11	70.43	-9.34	-10.04
Net Income Growth	-	-	69.20%	1135.01%	-	-
Shares Outstanding (Basic)	200	190	183	144	124	122
Shares Outstanding (Diluted)	200	190	195	162	124	122
Shares Change (YoY)	6.38%	-2.68%	20.96%	30.59%	1.76%	-
EPS (Basic)	-1.59	-0.43	0.64	0.49	-0.08	-0.08
EPS (Diluted)	-1.59	-0.43	0.59	0.44	-0.08	-0.08
EPS Growth	-	-	34.09%	-	-	-
Free Cash Flow	102.38	96.83	13.68	30.94	60.33	9.92
Free Cash Flow Per Share	0.51	0.51	0.07	0.19	0.49	0.08
Gross Margin	84.45%	83.63%	81.25%	82.72%	80.57%	79.15%
Operating Margin	14.59%	10.22%	0.39%	5.61%	5.68%	-0.88%
Profit Margin	-82.28%	-24.95%	42.90%	28.60%	-4.79%	-5.84%
Free Cash Flow Margin	26.58%	29.78%	5.05%	12.57%	30.95%	5.77%
EBITDA	67.17	43.74	10.73	20.9	16.95	2.56
EBITDA Margin	17.44%	13.46%	3.97%	8.49%	8.69%	1.49%
D&A For EBITDA	10.99	10.51	9.69	7.07	5.88	4.08
EBIT	56.18	33.24	1.04	13.82	11.07	-1.52
EBIT Margin	14.59%	10.22%	0.39%	5.61%	5.68%	-0.88%
Effective Tax Rate	-	-	-	13.25%	49.28%	232.58%
Revenue as Reported	385.17	325.11	270.65	246.25	194.91	171.85

Source: S&P Capital IQ. Standard template. Financial Sources.